ON DEMAND APRN-2-APRN Collaboration Call - Mind Matters: Innovative Strategies for Assessing and Managing Alzheimer's Disease
CE Information
1.0 contact hour (0.5 pharmacology)Completion Time
1 hour, 5 minutesAvailable Until
May 30, 2025
Navigate
Overview
An estimated 6.7 million people in the U.S. have Alzheimer’s disease (AD), the most common type of dementia. Approximately $345 billion is spent on treating and caring for persons with AD annually, not including the informal, unpaid care, estimated $339.5 billion, that caregivers provide.
In the community, 11% of adults aged 65 and older and 32% aged 85% and older have AD. Among hospitalized patients, 25% have AD or other forms of dementia. Despite these staggering statistics, AD is under-recognized, under-diagnosed, and under-managed, especially among the minority population.
This presentation will discuss the physiology of AD, as well as the assessment and management of AD in both primary and acute care settings. Screening tools and diagnostic workup of AD and distinguishing AD from other conditions with similar mentation changes, such as delirium and depression, will be presented. Current pharmacological treatments available for AD and non-pharmacological modalities, such as effective communication and approaches for common behavioral and psychological symptoms of AD (e.g., agitation, wandering, sundowning), will be discussed. Care planning for end-stage AD and providing resources to support family caregivers will be highlighted.
Learning Objectives
Participants will self-report the ability to identify at least two diagnostic results that will aid in distinguishing Alzheimer’s disease from other conditions such as delirium and depression.
Speakers
Dr. Ben Inventor began his nursing career in the Philippines. He continued his clinical experience in the U.S., working in various settings, including home health, long-term care, and acute care. After obtaining a Master of Science in Nursing degree as Adult/Geriatric nurse practitioner, he consulted with older adults in nursing homes. He received his PhD in Nursing Science from Rush University, where he examined the impact of activities, social environment, and psychotropic medications on neuropsychiatric symptoms of nursing home residents with dementia. His research interests focus on effective management of neuropsychiatric symptoms, reduction of psychotropic medication use, and caregiver skill building to provide person-centered dementia care. He is also interested in using pharmacogenomics to optimize therapeutic response and increase the safety of medications among older adults.
CE Information
This activity offers 1.0 contact hour (0.5 pharmacology) to attendees.
Accredited by Illinois Nurses Foundation is approved as a provider of nursing continuing professional development by the Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.
CE ANNOUNCEMENTS
The nurse planners, content experts’, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
JOINT‐PROVIDER
This program is jointly provided by the Illinois Nurses Foundation and the Illinois Society for Advanced Practice Nursing.
Disclosures
The nurse planners, content experts’, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
Activity Content
Duration: about 1 hour | Quality: UHD
4 questions
Access your certificate